Riobello, C.; Sánchez-Fernández, P.; Cabal, V.N.; García-Marín, R.; Suárez-Fernández, L.; Vivanco, B.; Blanco-Lorenzo, V.; Álvarez Marcos, C.; López, F.; Llorente, J.L.;
et al. Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma. Cancers 2021, 13, 5022.
https://doi.org/10.3390/cancers13195022
AMA Style
Riobello C, Sánchez-Fernández P, Cabal VN, García-Marín R, Suárez-Fernández L, Vivanco B, Blanco-Lorenzo V, Álvarez Marcos C, López F, Llorente JL,
et al. Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma. Cancers. 2021; 13(19):5022.
https://doi.org/10.3390/cancers13195022
Chicago/Turabian Style
Riobello, Cristina, Paula Sánchez-Fernández, Virginia N. Cabal, Rocío García-Marín, Laura Suárez-Fernández, Blanca Vivanco, Verónica Blanco-Lorenzo, César Álvarez Marcos, Fernando López, José Luis Llorente,
and et al. 2021. "Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma" Cancers 13, no. 19: 5022.
https://doi.org/10.3390/cancers13195022
APA Style
Riobello, C., Sánchez-Fernández, P., Cabal, V. N., García-Marín, R., Suárez-Fernández, L., Vivanco, B., Blanco-Lorenzo, V., Álvarez Marcos, C., López, F., Llorente, J. L., & Hermsen, M. A.
(2021). Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma. Cancers, 13(19), 5022.
https://doi.org/10.3390/cancers13195022